CONDENSED STATEMENTS OF CASH FLOWS - USD ($)	6 Months Ended
	Sep. 30, 2020	Sep. 30, 2019
Cash flows from operating activities:
Net income (loss)	$ (190,353)	$ 11,080,913
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities
Gain on disposition of Operating Partnerships	(430,992)	(11,850,663)
Changes in assets and liabilities
Increase in other assets	(13,650)	0
(Decrease) Increase in accounts payable and accrued expenses	9,218	(9,044)
(Decrease) Increase in accounts payable affiliates	(108,130)	(2,345,707)
Net cash provided by (used in) operating activities	(733,907)	(3,124,501)
Cash flows from investing activities:
Proceeds from the disposition of Operating Partnerships	430,992	11,850,561
Net cash provided by investing activities	430,992	11,850,561
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	(302,915)	8,726,060
Cash and cash equivalents, beginning	6,622,109	22,926,529
Cash and cash equivalents, ending	6,319,194	31,652,589
Supplemental schedule of noncash investing and financing activities:
The Fund applied notes receivable and advances to its capital contribution obligation to Operating Partnerships.	0	25,000
Series Twenty [Member]
Cash flows from operating activities:
Net income (loss)	0	0
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities
Gain on disposition of Operating Partnerships	0	0
Changes in assets and liabilities
Increase in other assets	0	0
(Decrease) Increase in accounts payable and accrued expenses	0	0
(Decrease) Increase in accounts payable affiliates	0	0
Net cash provided by (used in) operating activities	0	0
Cash flows from investing activities:
Proceeds from the disposition of Operating Partnerships	0	0
Net cash provided by investing activities	0	0
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	0	0
Cash and cash equivalents, beginning	0	0
Cash and cash equivalents, ending	0	0
Supplemental schedule of noncash investing and financing activities:
The Fund applied notes receivable and advances to its capital contribution obligation to Operating Partnerships.	0	0
Series Twenty One [Member]
Cash flows from operating activities:
Net income (loss)	0	0
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities
Gain on disposition of Operating Partnerships	0	0
Changes in assets and liabilities
Increase in other assets	0	0
(Decrease) Increase in accounts payable and accrued expenses	0	0
(Decrease) Increase in accounts payable affiliates	0	0
Net cash provided by (used in) operating activities	0	0
Cash flows from investing activities:
Proceeds from the disposition of Operating Partnerships	0	0
Net cash provided by investing activities	0	0
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	0	0
Cash and cash equivalents, beginning	0	0
Cash and cash equivalents, ending	0	0
Supplemental schedule of noncash investing and financing activities:
The Fund applied notes receivable and advances to its capital contribution obligation to Operating Partnerships.	0	0
Series Twenty Two [Member]
Cash flows from operating activities:
Net income (loss)	0	0
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities
Gain on disposition of Operating Partnerships	0	0
Changes in assets and liabilities
Increase in other assets	0	0
(Decrease) Increase in accounts payable and accrued expenses	0	0
(Decrease) Increase in accounts payable affiliates	0	0
Net cash provided by (used in) operating activities	0	0
Cash flows from investing activities:
Proceeds from the disposition of Operating Partnerships	0	0
Net cash provided by investing activities	0	0
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	0	0
Cash and cash equivalents, beginning	0	0
Cash and cash equivalents, ending	0	0
Supplemental schedule of noncash investing and financing activities:
The Fund applied notes receivable and advances to its capital contribution obligation to Operating Partnerships.	0	0
Series Twenty Three [Member]
Cash flows from operating activities:
Net income (loss)	0	0
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities
Gain on disposition of Operating Partnerships	0	0
Changes in assets and liabilities
Increase in other assets	0	0
(Decrease) Increase in accounts payable and accrued expenses	0	0
(Decrease) Increase in accounts payable affiliates	0	0
Net cash provided by (used in) operating activities	0	0
Cash flows from investing activities:
Proceeds from the disposition of Operating Partnerships	0	0
Net cash provided by investing activities	0	0
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	0	0
Cash and cash equivalents, beginning	0	0
Cash and cash equivalents, ending	0	0
Supplemental schedule of noncash investing and financing activities:
The Fund applied notes receivable and advances to its capital contribution obligation to Operating Partnerships.	0	0
Series Twenty Four [Member]
Cash flows from operating activities:
Net income (loss)	0	(39,827)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities
Gain on disposition of Operating Partnerships	0	0
Changes in assets and liabilities
Increase in other assets	0	0
(Decrease) Increase in accounts payable and accrued expenses	0	0
(Decrease) Increase in accounts payable affiliates	0	0
Net cash provided by (used in) operating activities	0	(39,827)
Cash flows from investing activities:
Proceeds from the disposition of Operating Partnerships	0	0
Net cash provided by investing activities	0	0
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	0	(39,827)
Cash and cash equivalents, beginning	0	402,018
Cash and cash equivalents, ending	0	362,191
Supplemental schedule of noncash investing and financing activities:
The Fund applied notes receivable and advances to its capital contribution obligation to Operating Partnerships.	0	0
Series Twenty Five [Member]
Cash flows from operating activities:
Net income (loss)	0	0
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities
Gain on disposition of Operating Partnerships	0	0
Changes in assets and liabilities
Increase in other assets	0	0
(Decrease) Increase in accounts payable and accrued expenses	0	0
(Decrease) Increase in accounts payable affiliates	0	0
Net cash provided by (used in) operating activities	0	0
Cash flows from investing activities:
Proceeds from the disposition of Operating Partnerships	0	0
Net cash provided by investing activities	0	0
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	0	0
Cash and cash equivalents, beginning	0	0
Cash and cash equivalents, ending	0	0
Supplemental schedule of noncash investing and financing activities:
The Fund applied notes receivable and advances to its capital contribution obligation to Operating Partnerships.	0	0
Series Twenty Six [Member]
Cash flows from operating activities:
Net income (loss)	(41,390)	(56,168)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities
Gain on disposition of Operating Partnerships	0	0
Changes in assets and liabilities
Increase in other assets	0	0
(Decrease) Increase in accounts payable and accrued expenses	165	0
(Decrease) Increase in accounts payable affiliates	4,282	0
Net cash provided by (used in) operating activities	(36,943)	(56,168)
Cash flows from investing activities:
Proceeds from the disposition of Operating Partnerships	0	0
Net cash provided by investing activities	0	0
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	(36,943)	(56,168)
Cash and cash equivalents, beginning	576,004	554,439
Cash and cash equivalents, ending	539,061	498,271
Supplemental schedule of noncash investing and financing activities:
The Fund applied notes receivable and advances to its capital contribution obligation to Operating Partnerships.	0	0
Series Twenty Seven [Member]
Cash flows from operating activities:
Net income (loss)	0	800,839
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities
Gain on disposition of Operating Partnerships	0	(776,922)
Changes in assets and liabilities
Increase in other assets	0	0
(Decrease) Increase in accounts payable and accrued expenses	0	0
(Decrease) Increase in accounts payable affiliates	0	0
Net cash provided by (used in) operating activities	0	23,917
Cash flows from investing activities:
Proceeds from the disposition of Operating Partnerships	0	776,922
Net cash provided by investing activities	0	776,922
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	0	800,839
Cash and cash equivalents, beginning	0	6,500,234
Cash and cash equivalents, ending	0	7,301,073
Supplemental schedule of noncash investing and financing activities:
The Fund applied notes receivable and advances to its capital contribution obligation to Operating Partnerships.	0	0
Series Twenty Eight [Member]
Cash flows from operating activities:
Net income (loss)	0	(30,463)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities
Gain on disposition of Operating Partnerships	0	(7,100)
Changes in assets and liabilities
Increase in other assets	0	0
(Decrease) Increase in accounts payable and accrued expenses	0	0
(Decrease) Increase in accounts payable affiliates	0	0
Net cash provided by (used in) operating activities	0	(37,563)
Cash flows from investing activities:
Proceeds from the disposition of Operating Partnerships	0	7,100
Net cash provided by investing activities	0	7,100
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	0	(30,463)
Cash and cash equivalents, beginning	0	690,605
Cash and cash equivalents, ending	0	660,142
Supplemental schedule of noncash investing and financing activities:
The Fund applied notes receivable and advances to its capital contribution obligation to Operating Partnerships.	0	0
Series Twenty Nine [Member]
Cash flows from operating activities:
Net income (loss)	(30,805)	(42,141)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities
Gain on disposition of Operating Partnerships	(9,500)	0
Changes in assets and liabilities
Increase in other assets	0	0
(Decrease) Increase in accounts payable and accrued expenses	159	0
(Decrease) Increase in accounts payable affiliates	13,505	14,520
Net cash provided by (used in) operating activities	(26,641)	(27,621)
Cash flows from investing activities:
Proceeds from the disposition of Operating Partnerships	9,500	0
Net cash provided by investing activities	9,500	0
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	(17,141)	(27,621)
Cash and cash equivalents, beginning	157,446	196,944
Cash and cash equivalents, ending	140,305	169,323
Supplemental schedule of noncash investing and financing activities:
The Fund applied notes receivable and advances to its capital contribution obligation to Operating Partnerships.	0	0
Series Thirty [Member]
Cash flows from operating activities:
Net income (loss)	0	0
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities
Gain on disposition of Operating Partnerships	0	0
Changes in assets and liabilities
Increase in other assets	0	0
(Decrease) Increase in accounts payable and accrued expenses	0	0
(Decrease) Increase in accounts payable affiliates	0	0
Net cash provided by (used in) operating activities	0	0
Cash flows from investing activities:
Proceeds from the disposition of Operating Partnerships	0	0
Net cash provided by investing activities	0	0
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	0	0
Cash and cash equivalents, beginning	0	0
Cash and cash equivalents, ending	0	0
Supplemental schedule of noncash investing and financing activities:
The Fund applied notes receivable and advances to its capital contribution obligation to Operating Partnerships.	0	0
Series Thirty One [Member]
Cash flows from operating activities:
Net income (loss)	0	654,911
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities
Gain on disposition of Operating Partnerships	0	(618,900)
Changes in assets and liabilities
Increase in other assets	0	0
(Decrease) Increase in accounts payable and accrued expenses	0	0
(Decrease) Increase in accounts payable affiliates	0	0
Net cash provided by (used in) operating activities	0	36,011
Cash flows from investing activities:
Proceeds from the disposition of Operating Partnerships	0	618,900
Net cash provided by investing activities	0	618,900
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	0	654,911
Cash and cash equivalents, beginning	0	1,953,570
Cash and cash equivalents, ending	0	2,608,481
Supplemental schedule of noncash investing and financing activities:
The Fund applied notes receivable and advances to its capital contribution obligation to Operating Partnerships.	0	25,000
Series Thirty Two [Member]
Cash flows from operating activities:
Net income (loss)	(43,279)	(51,389)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities
Gain on disposition of Operating Partnerships	0	0
Changes in assets and liabilities
Increase in other assets	0	0
(Decrease) Increase in accounts payable and accrued expenses	163	0
(Decrease) Increase in accounts payable affiliates	30,264	(11,620)
Net cash provided by (used in) operating activities	(12,852)	(63,009)
Cash flows from investing activities:
Proceeds from the disposition of Operating Partnerships	0	0
Net cash provided by investing activities	0	0
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	(12,852)	(63,009)
Cash and cash equivalents, beginning	193,203	272,226
Cash and cash equivalents, ending	180,351	209,217
Supplemental schedule of noncash investing and financing activities:
The Fund applied notes receivable and advances to its capital contribution obligation to Operating Partnerships.	0	0
Series Thirty Three [Member]
Cash flows from operating activities:
Net income (loss)	(28,440)	1,423,100
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities
Gain on disposition of Operating Partnerships	0	(1,442,632)
Changes in assets and liabilities
Increase in other assets	0	0
(Decrease) Increase in accounts payable and accrued expenses	89	0
(Decrease) Increase in accounts payable affiliates	9,777	(1,099,287)
Net cash provided by (used in) operating activities	(18,574)	(1,118,819)
Cash flows from investing activities:
Proceeds from the disposition of Operating Partnerships	0	1,442,632
Net cash provided by investing activities	0	1,442,632
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	(18,574)	323,813
Cash and cash equivalents, beginning	561,941	236,612
Cash and cash equivalents, ending	543,367	560,425
Supplemental schedule of noncash investing and financing activities:
The Fund applied notes receivable and advances to its capital contribution obligation to Operating Partnerships.	0	0
Series Thirty Four [Member]
Cash flows from operating activities:
Net income (loss)	(41,173)	216,071
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities
Gain on disposition of Operating Partnerships	0	(257,500)
Changes in assets and liabilities
Increase in other assets	0	0
(Decrease) Increase in accounts payable and accrued expenses	122	0
(Decrease) Increase in accounts payable affiliates	13,454	23,861
Net cash provided by (used in) operating activities	(27,597)	(17,568)
Cash flows from investing activities:
Proceeds from the disposition of Operating Partnerships	0	257,500
Net cash provided by investing activities	0	257,500
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	(27,597)	239,932
Cash and cash equivalents, beginning	148,344	178,285
Cash and cash equivalents, ending	120,747	418,217
Supplemental schedule of noncash investing and financing activities:
The Fund applied notes receivable and advances to its capital contribution obligation to Operating Partnerships.	0	0
Series Thirty Five [Member]
Cash flows from operating activities:
Net income (loss)	0	132,796
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities
Gain on disposition of Operating Partnerships	0	(141,000)
Changes in assets and liabilities
Increase in other assets	0	0
(Decrease) Increase in accounts payable and accrued expenses	0	0
(Decrease) Increase in accounts payable affiliates	0	0
Net cash provided by (used in) operating activities	0	(8,204)
Cash flows from investing activities:
Proceeds from the disposition of Operating Partnerships	0	141,000
Net cash provided by investing activities	0	141,000
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	0	132,796
Cash and cash equivalents, beginning	0	4,395,774
Cash and cash equivalents, ending	0	4,528,570
Supplemental schedule of noncash investing and financing activities:
The Fund applied notes receivable and advances to its capital contribution obligation to Operating Partnerships.	0	0
Series Thirty Six [Member]
Cash flows from operating activities:
Net income (loss)	0	465,273
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities
Gain on disposition of Operating Partnerships	0	(476,325)
Changes in assets and liabilities
Increase in other assets	0	0
(Decrease) Increase in accounts payable and accrued expenses	0	(4,900)
(Decrease) Increase in accounts payable affiliates	0	0
Net cash provided by (used in) operating activities	0	(15,952)
Cash flows from investing activities:
Proceeds from the disposition of Operating Partnerships	0	476,325
Net cash provided by investing activities	0	476,325
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	0	460,373
Cash and cash equivalents, beginning	0	2,541,359
Cash and cash equivalents, ending	0	3,001,732
Supplemental schedule of noncash investing and financing activities:
The Fund applied notes receivable and advances to its capital contribution obligation to Operating Partnerships.	0	0
Series Thirty Seven [Member]
Cash flows from operating activities:
Net income (loss)	0	0
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities
Gain on disposition of Operating Partnerships	0	0
Changes in assets and liabilities
Increase in other assets	0	0
(Decrease) Increase in accounts payable and accrued expenses	0	0
(Decrease) Increase in accounts payable affiliates	0	0
Net cash provided by (used in) operating activities	0	0
Cash flows from investing activities:
Proceeds from the disposition of Operating Partnerships	0	0
Net cash provided by investing activities	0	0
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	0	0
Cash and cash equivalents, beginning	0	0
Cash and cash equivalents, ending	0	0
Supplemental schedule of noncash investing and financing activities:
The Fund applied notes receivable and advances to its capital contribution obligation to Operating Partnerships.	0	0
Series Thirty Eight [Member]
Cash flows from operating activities:
Net income (loss)	0	1,442,036
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities
Gain on disposition of Operating Partnerships	0	(1,463,974)
Changes in assets and liabilities
Increase in other assets	0	0
(Decrease) Increase in accounts payable and accrued expenses	0	0
(Decrease) Increase in accounts payable affiliates	0	0
Net cash provided by (used in) operating activities	0	(21,938)
Cash flows from investing activities:
Proceeds from the disposition of Operating Partnerships	0	1,463,974
Net cash provided by investing activities	0	1,463,974
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	0	1,442,036
Cash and cash equivalents, beginning	0	1,499,106
Cash and cash equivalents, ending	0	2,941,142
Supplemental schedule of noncash investing and financing activities:
The Fund applied notes receivable and advances to its capital contribution obligation to Operating Partnerships.	0	0
Series Thirty Nine [Member]
Cash flows from operating activities:
Net income (loss)	0	0
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities
Gain on disposition of Operating Partnerships	0	0
Changes in assets and liabilities
Increase in other assets	0	0
(Decrease) Increase in accounts payable and accrued expenses	0	0
(Decrease) Increase in accounts payable affiliates	0	0
Net cash provided by (used in) operating activities	0	0
Cash flows from investing activities:
Proceeds from the disposition of Operating Partnerships	0	0
Net cash provided by investing activities	0	0
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	0	0
Cash and cash equivalents, beginning	0	0
Cash and cash equivalents, ending	0	0
Supplemental schedule of noncash investing and financing activities:
The Fund applied notes receivable and advances to its capital contribution obligation to Operating Partnerships.	0	0
Series Forty [Member]
Cash flows from operating activities:
Net income (loss)	0	2,500,441
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities
Gain on disposition of Operating Partnerships	0	(2,554,005)
Changes in assets and liabilities
Increase in other assets	0	0
(Decrease) Increase in accounts payable and accrued expenses	0	(4,144)
(Decrease) Increase in accounts payable affiliates	0	(1,148,217)
Net cash provided by (used in) operating activities	0	(1,205,925)
Cash flows from investing activities:
Proceeds from the disposition of Operating Partnerships	0	2,553,903
Net cash provided by investing activities	0	2,553,903
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	0	1,347,978
Cash and cash equivalents, beginning	0	193,344
Cash and cash equivalents, ending	0	1,541,322
Supplemental schedule of noncash investing and financing activities:
The Fund applied notes receivable and advances to its capital contribution obligation to Operating Partnerships.	0	0
Series Forty One [Member]
Cash flows from operating activities:
Net income (loss)	(34,276)	(33,697)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities
Gain on disposition of Operating Partnerships	(46,500)	0
Changes in assets and liabilities
Increase in other assets	0	0
(Decrease) Increase in accounts payable and accrued expenses	2,599	0
(Decrease) Increase in accounts payable affiliates	56,378	68,154
Net cash provided by (used in) operating activities	(21,799)	34,457
Cash flows from investing activities:
Proceeds from the disposition of Operating Partnerships	46,500	0
Net cash provided by investing activities	46,500	0
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	24,701	34,457
Cash and cash equivalents, beginning	352,239	246,214
Cash and cash equivalents, ending	376,940	280,671
Supplemental schedule of noncash investing and financing activities:
The Fund applied notes receivable and advances to its capital contribution obligation to Operating Partnerships.	0	0
Series Forty Two [Member]
Cash flows from operating activities:
Net income (loss)	(71,098)	(58,859)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities
Gain on disposition of Operating Partnerships	0	0
Changes in assets and liabilities
Increase in other assets	0	0
(Decrease) Increase in accounts payable and accrued expenses	88	0
(Decrease) Increase in accounts payable affiliates	19,260	0
Net cash provided by (used in) operating activities	(51,750)	(58,859)
Cash flows from investing activities:
Proceeds from the disposition of Operating Partnerships	0	0
Net cash provided by investing activities	0	0
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	(51,750)	(58,859)
Cash and cash equivalents, beginning	1,607,893	1,300,483
Cash and cash equivalents, ending	1,556,143	1,241,624
Supplemental schedule of noncash investing and financing activities:
The Fund applied notes receivable and advances to its capital contribution obligation to Operating Partnerships.	0	0
Series Forty Three [Member]
Cash flows from operating activities:
Net income (loss)	42,468	1,186,830
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities
Gain on disposition of Operating Partnerships	(106,800)	(1,255,582)
Changes in assets and liabilities
Increase in other assets	(13,650)	0
(Decrease) Increase in accounts payable and accrued expenses	15,996	0
(Decrease) Increase in accounts payable affiliates	19,371	(168,259)
Net cash provided by (used in) operating activities	(42,615)	(237,011)
Cash flows from investing activities:
Proceeds from the disposition of Operating Partnerships	106,800	1,255,582
Net cash provided by investing activities	106,800	1,255,582
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	64,185	1,018,571
Cash and cash equivalents, beginning	1,416,291	414,540
Cash and cash equivalents, ending	1,480,476	1,433,111
Supplemental schedule of noncash investing and financing activities:
The Fund applied notes receivable and advances to its capital contribution obligation to Operating Partnerships.	0	0
Series Forty Four [Member]
Cash flows from operating activities:
Net income (loss)	(70,650)	2,763,147
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities
Gain on disposition of Operating Partnerships	0	(2,856,723)
Changes in assets and liabilities
Increase in other assets	0	0
(Decrease) Increase in accounts payable and accrued expenses	(3,907)	0
(Decrease) Increase in accounts payable affiliates	60,630	(132,745)
Net cash provided by (used in) operating activities	(13,927)	(226,321)
Cash flows from investing activities:
Proceeds from the disposition of Operating Partnerships	0	2,856,723
Net cash provided by investing activities	0	2,856,723
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	(13,927)	2,630,402
Cash and cash equivalents, beginning	321,693	113,020
Cash and cash equivalents, ending	307,766	2,743,422
Supplemental schedule of noncash investing and financing activities:
The Fund applied notes receivable and advances to its capital contribution obligation to Operating Partnerships.	0	0
Series Forty Five [Member]
Cash flows from operating activities:
Net income (loss)	132,157	(117,120)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities
Gain on disposition of Operating Partnerships	(199,692)	0
Changes in assets and liabilities
Increase in other assets	0	0
(Decrease) Increase in accounts payable and accrued expenses	(6,360)	0
(Decrease) Increase in accounts payable affiliates	(429,873)	3,288
Net cash provided by (used in) operating activities	(503,768)	(113,832)
Cash flows from investing activities:
Proceeds from the disposition of Operating Partnerships	199,692	0
Net cash provided by investing activities	199,692	0
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	(304,076)	(113,832)
Cash and cash equivalents, beginning	859,371	916,581
Cash and cash equivalents, ending	555,295	802,749
Supplemental schedule of noncash investing and financing activities:
The Fund applied notes receivable and advances to its capital contribution obligation to Operating Partnerships.	0	0
Series Forty Six [Member]
Cash flows from operating activities:
Net income (loss)	(3,867)	(74,867)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities
Gain on disposition of Operating Partnerships	(68,500)	0
Changes in assets and liabilities
Increase in other assets	0	0
(Decrease) Increase in accounts payable and accrued expenses	104	0
(Decrease) Increase in accounts payable affiliates	94,822	104,598
Net cash provided by (used in) operating activities	22,559	29,731
Cash flows from investing activities:
Proceeds from the disposition of Operating Partnerships	68,500	0
Net cash provided by investing activities	68,500	0
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	91,059	29,731
Cash and cash equivalents, beginning	427,684	321,175
Cash and cash equivalents, ending	518,743	350,906
Supplemental schedule of noncash investing and financing activities:
The Fund applied notes receivable and advances to its capital contribution obligation to Operating Partnerships.	$ 0	$ 0